Gainers
Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday.
The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P 500, also fell, dropping, 0.01% to 4,378.08.
Minerva Neurosciences, Inc (NASDAQ: NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded down 0.30% to 33,823.27 while the NASDAQ fell 0.22% to 13,525.21. The S&P 500, also fell, dropping, 0.31% to 4,364.76.
Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that it has agreed to
Companies Reporting Before The Bell
• Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter.
• Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.